| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |